These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 33627393

  • 1. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    Ikeda H, Uchida H, Okubo Y, Shibata T, Sasaki Y, Suzuki T, Hamada-Uematsu M, Hamasaki R, Okuda K, Yamaguchi M, Kojima M, Tanaka M, Hamada H, Tahara H.
    J Virol; 2021 Apr 12; 95(9):. PubMed ID: 33627393
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.
    Petrovic B, Leoni V, Gatta V, Zaghini A, Vannini A, Campadelli-Fiume G.
    J Virol; 2018 Mar 15; 92(6):. PubMed ID: 29263257
    [Abstract] [Full Text] [Related]

  • 5. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
    Leoni V, Gatta V, Casiraghi C, Nicosia A, Petrovic B, Campadelli-Fiume G.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28250120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.
    Menotti L, Avitabile E, Gatta V, Malatesta P, Petrovic B, Campadelli-Fiume G.
    Viruses; 2018 Jun 30; 10(7):. PubMed ID: 29966356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.
    Petrovic B, Gianni T, Gatta V, Campadelli-Fiume G.
    PLoS Pathog; 2017 Apr 30; 13(4):e1006352. PubMed ID: 28423057
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.
    Rogalin HB, Heldwein EE.
    J Virol; 2016 Nov 15; 90(22):10321-10328. PubMed ID: 27605677
    [Abstract] [Full Text] [Related]

  • 12. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
    Patrusheva I, Perelygina L, Torshin I, LeCher J, Hilliard J.
    J Virol; 2016 Oct 15; 90(20):9420-32. PubMed ID: 27512063
    [Abstract] [Full Text] [Related]

  • 13. A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein.
    Conner J, Braidwood L, Brown SM.
    Gene Ther; 2008 Dec 15; 15(24):1579-92. PubMed ID: 18701918
    [Abstract] [Full Text] [Related]

  • 14. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection.
    Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, Glorioso JC.
    J Virol; 2010 Dec 15; 84(23):12200-9. PubMed ID: 20861246
    [Abstract] [Full Text] [Related]

  • 15. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.
    Fan Q, Kopp S, Connolly SA, Muller WJ, Longnecker R.
    Sci Rep; 2017 Mar 03; 7():43712. PubMed ID: 28255168
    [Abstract] [Full Text] [Related]

  • 16. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
    Connolly SA, Whitbeck JJ, Rux AH, Krummenacher C, van Drunen Littel-van den Hurk S, Cohen GH, Eisenberg RJ.
    Virology; 2001 Feb 01; 280(1):7-18. PubMed ID: 11162814
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
    Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH.
    J Virol; 1998 May 01; 72(5):3595-601. PubMed ID: 9557640
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
    Menotti L, Nicoletti G, Gatta V, Croci S, Landuzzi L, De Giovanni C, Nanni P, Lollini PL, Campadelli-Fiume G.
    Proc Natl Acad Sci U S A; 2009 Jun 02; 106(22):9039-44. PubMed ID: 19458262
    [Abstract] [Full Text] [Related]

  • 19. Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes.
    Hilterbrand AT, Daly RE, Heldwein EE.
    mBio; 2021 Mar 02; 12(2):. PubMed ID: 33653890
    [Abstract] [Full Text] [Related]

  • 20. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1.
    Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y.
    Nature; 2010 Oct 14; 467(7317):859-62. PubMed ID: 20944748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.